Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 5308-28-1 | MDL No. : | MFCD00190596 |
Formula : | C8H18N2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | HUUQNWZMQSLPMX-UHFFFAOYSA-N |
M.W : | 142.24 | Pubchem ID : | 2052052 |
Synonyms : |
|
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P301+P312-P302+P352-P304+P340-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
44% | With triethylamine In ethanol for 72h; Heating; | |
With toluene at 90℃; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With toluene |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With sodium hydroxide In ethanol for 28h; Heating; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With diphenylphosphoranyl azide; triethylamine 1.) DMF, 130 deg C, 2 h, 2.) NMP, 200 deg C, 30 min; Multistep reaction; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
23% | With diethyl cyanophosphonate; triethylamine In N,N-dimethyl-formamide 1.) 0-5 deg C, 30 min; 2.) rt, 1.5 h; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
53% | With manganese(IV) oxide In dimethyl sulfoxide for 24h; Ambient temperature; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
67% | In acetonitrile for 17h; Heating; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With trifluoroacetic acid for 16h; Ambient temperature; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With sodium iodide In N,N-dimethyl-formamide |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
N-Isobutyl-N'-formylpiperazin If, HCl; | ||
Piperazin, Isobutylbromid in abs. EtOH; | ||
entspr. N-Phenylpiperazin, 1) NaNO2/HCl, 2) SO2, Erhitz.; |
1-Ethoxycarbonyl-piperazin, 1.) p-Toluolsulfonsaeure-isobutylester, abs. EtOH, 2.) 20 percentige HCl, Siedetemp.; | ||
1-Phenyl-4-isobutyl-piperazin, 1. HNO2, 2. wss. KOH; | ||
(yield)40percent; | ||
Specific examples of the compounds of the formula (6) are given below. ... 1-ethylpiperazine, 1-propylpiperazine, 1-isopropylpiperazine, 1-butylpiperazine, 1-isobutylpiperazine, 1-sec-butylpiperazine. | ||
R.6 Synthesis of 1-isobutylpiperazine Reference Example 6 Synthesis of 1-isobutylpiperazine To 1-isobutylpiperazine dihydrochloride (69.5 g) was added 10% aqueous sodium hydroxide solution (100 ml) and then the resulting mixture was extracted with ether. After the extract was concentrated, the residue was distilled under reduced pressure (bp: 172° to 174° C./5 mmHg), thereby yielding 43.7 g of the aimed compound. | ||
R.29 Synthesis of 4-(2-aminoethyl)-1-isobutylpiperazine To 1-isobutylpiperazine dihydrochloride(69.5 g) was added 10% aqueous solution of sodium hydrochloride(100 ml) and the mixture was extracted with ether. After being concentrated, the extract was distilled under a vacuum(bp 172°-174° C./5 mmHg), thereby yielding 43.7 g of 1-isobutylpiperazine. | ||
With hydrogenchloride In 1,4-dioxane at 20℃; for 3h; | I.2.2 Step 2. Synthesis of 1- (5- (trifluoromethyl) pyridin-2-yl) piperazine (A-8) General procedure: 1- (5- (trifluoromethyl) pyridin-2-yl) piperazine (13.3 g, 40.0 mmol) was added to 150 mL of a 4N hydrochloric acid-dioxane solution, and the reaction was stirred at room temperature for 3 hours, and the solvent was distilled off under reduced pressure. The residue was adjusted to pH 8-9 with 15% Na2CO3 solution, extracted twice with ethyl acetate, and the organic layers were combined, washed with water and saturated NaCl aqueous solution, and dried with anhydrous Na2SO4 to obtain 8.42 g of A-8, yield 91. %, |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With triethylamine; xylene |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With copper; potassium carbonate; xylene |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In acetone at 20℃; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With TEA; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
75.4% | With potassium carbonate In ethanol Heating; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
40.5% | With triethylamine In N,N-dimethyl-formamide Heating; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With triethylamine In N,N-dimethyl-formamide at 20℃; | 131 Methanesulfonic acid 2-(lH-indol-4-yl)-4~morpholin~4-yl-thieno[3,2- d]pyrimidin-6-ylmethyl ester, amine and triethylamine were mixed together in DMF and stirred at room temperature. When the reaction was judged to be complete, the solvent was removed under reduced pressure, the residue dissolved in DMSO and purified by preparative HPLC. The chromatographic solvents were removed under reduced pressure to afford the product > 85% purity. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With manganese(IV) oxide In dimethyl sulfoxide at 20℃; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With manganese(IV) oxide In dimethyl sulfoxide at 20℃; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With manganese(IV) oxide In dimethyl sulfoxide at 20℃; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: TEA / dimethylformamide / 80 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: 53 percent / manganese dioxide / dimethylsulfoxide / 24 h / Ambient temperature 2: 69 percent / sodium hydroxide, water / ethanol / 2 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With cyclohexane; potassium carbonate; potassium iodide In water; xylene | 1.B Alternate Example 1B 1-{5-[4-(3,4-dichloro-phenyl)-1H-imidazol-2-yl]-pyridin-2-yl}-4-isobutyl-piperazine Alternate Example 1B 1-{5-[4-(3,4-dichloro-phenyl)-1H-imidazol-2-yl]-pyridin-2-yl}-4-isobutyl-piperazine. A suspension of 2-chloro-5-[4-(3,4-dichloro-phenyl)-1H-imidazol-2-yl]-pyridine dihydrochloride (1.07 g, 2.6 mmol), N-isobutylpiperazine (0.95 g, 6.72 mmol), potassium carbonate (0.5 g, 3.62 mmol), and potassium iodide (0.5 g, 0.54 mmol) in xylenes (5 ML) was heated to reflux under a nitrogen atmosphere for 24 hours.. The reaction mixture was then cooled to ambient temperature and a solution of potassium carbonate (19) in water (10 ML) and cyclohexane (10 ML) were added.. The mixture was stirred vigorously for 15 min, and the precipitate was collected by filtration.. The filter cake was washed with water (10 ML) and triturated with methyl tert-butyl ether (4 ML) to provide 1-{5-[5(3,4-dichloro-phenyl)-1H-imidazol-2-yl]-pyridin-2-yl}-4-isobutyl-piperazine (2.07 mmol). MS m/z 430 (M++1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
86.2% | With palladium 10% on activated carbon; hydrogen at 20℃; for 20h; | 1-Cyclohexylpyrrolidin-3-amine I-6 General procedure: To a solution of compound I-5 (240 mg) in HFIP (8 mL), 10% Pd/C (120 mg) was added and thenthe reaction mixture was stirred under H2 at room temperature and 1atm for 20 h. Then themixture was filtrated and the filtrate was concentrated to give compound I-6 as yellow oil (100 mg,75%). |
With hydrogen In ethanol at 20℃; for 12h; | 2 Benzyl 1-piperazinecarboxylate (1.1 g, 5.00 mmol) and isobutylaldehyde (0.91 mL, 10.0 mmol) were dissolved in 30 mL of tetrahydrofuran, and acetic acid (0.57 mL, 10.0 mmol) and sodium triacetoxyborohydride (2.11 g, 10.0 mmol) were added thereto, and the reaction mixture was stirred at room temperature for two hours. The reaction mixture was mixed with a 1N aqueous solution of sodium hydroxide, extracted with ethyl acetate twice, and the combined organic layers were washed with brine once. The mixture was dried over anhydrous sodium sulfate and evaporated. The resulting residue was purified by silica gel column chromatography (Fuji Silysia, NH Silica gel; ethyl acetate:hexane=50:50) to give benzyl 4-isobutylpiperazin-1-carboxylate (1.05 g) as a colorless oil. The resulting benzyl 4-isobutylpiperazin-1-carboxylate (1.05 g) was dissolved in 35 mL of ethanol, 10% palladium-carbon (750 mg) was added thereto, and the reaction mixture was stirred at room temperature under hydrogen atmosphere (1 atm) for 12 hours. The palladium-carbon was removed by filtration, and the filtrate was evaporated to give the title compound (610 mg) as a colorless oil.1H-NMR Spectrum (CDCl3,400MHz) δ(ppm): 0.90(6H,d,J=6.8Hz), 1.71-1.86(1H,m),2.07(2H,d,J=7.6Hz),2.33-2.43(4H,m),2.86-2.93(4H,m). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With manganese(IV) oxide In dimethyl sulfoxide at 20℃; for 120h; | 68 [0444] The general coupling procedure of Example 1 is used to prepare the title compound. To compound 124 (0.20 g) in 3 mL of dimethyl sulfoxide is added 100 mg of 4-isobutylpiperazine and 0.2 g of manganese dioxide. The mixture stirred at room temperature for 5 days. The reaction mixture is diluted by addition of ethyl acetate and insoluble substances are filtered off. The filtrate is washed successively with water and with a saturated aqueous solution of sodium chloride, and dried over anhydrous sodium sulfate. After the drying agent is filtered off, the solvent is removed under reduced pressure. The residue is purified twice by silica-gel column-chromatography [eluent: ethyl acetate/hexane, 1:1 to 9:1 gradient] to give 25-O-deacetyl-25-(2 ,3 -dihydroxypropylcarbonoxy)-21,23-(1-methylethylidene acetal)-5'-[4-isobutyl-1-piperazinyl]benzoxazinorifamycin (compound 125). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With potassium iodide; potassium carbonate In cyclohexane; water | A.1.B 1-{5-[4-(3,4-dichloro-phenyl)-1H-imidazol-2-yl]-pyridin-2-yl}-4-isobutyl-piperazine. ALTERNATE EXAMPLE 1B 1-{5-[4-(3,4-dichloro-phenyl)-1H-imidazol-2-yl]-pyridin-2-yl}-4-isobutyl-piperazine. A suspension of 2-chloro-5-[4-(3,4-dichloro-phenyl)-1H-imidazol-2-yl]-pyridine dihydrochloride (1.07 g, 2.6 mmol), N-isobutylpiperazine (0.95 g, 6.72 mmol), potassium carbonate (0.5 g, 3.62 mmol), and potassium iodide (0.5 g, 0.54 mmol) in xylenes (5 mL) was heated to reflux under a nitrogen atmosphere for 24 hours. The reaction mixture was then cooled to ambient temperature and a solution of potassium carbonate (1 g) in water (10 mL) and cyclohexane (10 mL) were added. The mixture was stirred vigorously for 15 min, and the precipitate was collected by filtration. The filter cake was washed with water (10 mL) and triturated with methyl tert-butyl ether (4 mL) to provide 1-{5-[5-(3,4-dichloro-phenyl)-1H-imidazol-2-yl]-pyridin-2-yl}-4-isobutyl-piperazine (2.07 mmol). MS m/z 430 (M++1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
94% | In ethanol | 14.E.B B. B. 4-[4-(isobutyl)-1-piperazinyl]benzenamine A mixture of 1-(isobutyl)-4-(4-nitrophenylpiperazine) (9.4 g, 35.7 mmol) (from Step A above) and 10% palladium-on-charcoal in ethanol (175 mL) was hydrogenated at room temperature at 20 psi for 1.25 hour. The catalyst was filtered off and the filter cake washed thoroughly with ethanol. The mixture was evaporated under reduced pressure to give 4-[4-(isobutyl)-1-piperazinyl] benzenamine (7.8 g, 94%) as a dark red solid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
5 1-[4-(4-fluorobenzyloxy)benzoyl]-4-isobutylpiperazine EXAMPLE 5 1-[4-(4-fluorobenzyloxy)benzoyl]-4-isobutylpiperazine It was synthesised in the manner identical to Example 3. Namely, ethyl 4-hydroxybenzoate (2.50 g) was benzylated with 4-fluorobenzyl bromide (2.84 g) and then hydrolyzed. From thus obtained 3.57 g of 4-(4-fluorobenzyloxy) benzoic acid, 1.24 g was subjected to a condensation reaction with 1-isobutylpiperazine (0.71 g), thereby yielding 1.08 g of the aimed compound. mp 109.0°-110.2° C.; 1 H-NMR (CDCl3)δ: 7.41(2H, d, J=8.8 Hz), 7.38(2H, d, J=8.8Hz), 7.08(2H, t, J=8.8 Hz), 6.96(2H, d, J=8.8 Hz), 5.05(2H, s), 3.85-3.35(4H, m), 2.50-2.25(4H, m), 2.10(2H, d, J=7.3 Hz), 1.88-1.71(1H, m), 0.90(6H, d, J=6.8 Hz). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
R.29 Synthesis of 4-(2-aminoethyl)-1-isobutylpiperazine By using 1-isobutylpiperazine (2.84 g) and bromoacetonitrile(2.40 g), as in the case of Reference Example 28, 1.19 g (15%) of 4-(2-aminoethyl)-1-isobutylpiperazine was obtained. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In hexane; chloroform; triethylamine | 21 1-[4-(4-fluorobenzyloxy)-3-isobutylbenzoyl]-4-isobutylpiperazine EXAMPLE 21 1-[4-(4-fluorobenzyloxy)-3-isobutylbenzoyl]-4-isobutylpiperazine 4-(4-fluorobenzyloxy)-3-isobutylbenzoic acid (16.5 g) was dissolved in a mixture of chloroform (150 ml) and triethylamine (15.3 ml). To this mixture was added diphenylphosphinic chloride (11.5 ml) while being cooled with ice. After being stirred for 40 minutes, the mixture, with 1-isobutylpiperazine (7.83 g) added thereto, was stirred for 1.5 hours at room temperature. This reaction mixture was washed with saturated sodium hydrogencarbonate solution and saturated brine successively, dried over sodium sulfate anhydride, and then concentrated under a vacuum. Thus obtained residue was purified by silica gel column chromatography (chloroform: methanol=50:1) and the resulting solid was recrystallized (from n-hexane), thereby yielding 19.6 g of the aimed compound. mp 77.0°-78.0° C.; 1 H-NMR (CDCl3)δ: 7.39(2H, dd, J=8.8,5.4 Hz), 7.25(1H, d, J=8.8 Hz), 7.17(1H, s), 7.08(2H, t, J=8.8 Hz), 6.87(1H, d, J=8.8 Hz), 5.05(2H, s), 3.90-3.35(4H, m), 2.53(2H, d, J=6.8 Hz), 2.55-2.25(4H, m), 2.10(2H, d, J=7.3 Hz), 2.01-1.91(1H, m), 1.88-1.71(1H, m), 0.90(6H, d, J=6.4 Hz), 0.89(6H, d, J=6.8 Hz). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
4 1-[4-(4-fluorobenzyloxy)-3-methallylbenzoyl]-4-isobutylpiperazine hydrochloride As in the case of Example 16, this compound (2.13 g) was subjected to a condensation reaction with 1-isobutylpiperazine (1.01 g), thereby yielding 1-[4(4-fluorobenzyloxy)-3-methallylbenzoyl]-4-isobutylpiperazine. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In chloroform; triethylamine | 16 1-(4-benzyloxy-3-isobutylbenzoyl)-4-isobutylpiperazine EXAMPLE 16 1-(4-benzyloxy-3-isobutylbenzoyl)-4-isobutylpiperazine 4-benzyloxy-3-isobutylbenzoic acid (4.94 g) was dissolved in a mixture of chloroform (60 ml) and triethylamine (4.83 ml). To this mixture, diphenylphosphinic chloride (3.66 ml) was added while being cooled with ice. After being stirred for 40 minutes, the mixture, with 1-isobutylpiperazine (2.48 g) added thereto, was stirred for 1.5 hours at room temperature. The reaction mixture was washed with saturated aqueous sodium hydrogencarbonate solution and saturated brine successively, dried over sodium sulfate anhydride, and then concentrated under a vacuum. Thus obtained residue was purified by silica gel column chromatography (chloroform: methanol=50:1), thereby yielding 7.11 g of the aimed compound. 1 H-NMR (CDCl3)δ: 7.44-7.37(4H, m), 7.33(1H, d, J=8.8 Hz), 7.26-7.23(1H, m), 7.17(1H, s), 6.89(1H, d, J=8.8 Hz), 5.10(2H, s), 3.90-3.35(4H, m), 2.55(2H, d, J=7.3 Hz), 2.55-2.25(4H, m), 2.10(2H, d, J=7.3 Hz), 2.01-1.91(1H, m), 1.88-1.71(1H, m), 0.91(6H, d, J=6.8 Hz), 0.90(6H, d, J=6.8 Hz). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
78% | With sodium hydroxide; potassium carbonate In chloroform methanol; chloroform | 9 EXAMPLE 9 EXAMPLE 9 In 30 ml of chloroform were added 1.42 g of 1-isobutylpiperazine and 2.76 g of potassium carbonate, and to the mixture was added dropwise 50 ml of a chloroform solution containing 2.28 g of 5-isoquinolinesulfonyl chloride under cooling with ice. After the dropwise addition of the chloroform solution, the mixed solution thus obtained was stirred at a temperature of 15° C. to 25° C. for two hours, and then the reaction solution was washed with 20 ml of a 1N aqueous sodium hydroxide solution and extracted twice with a 5N aqueous hydrochloric acid solution. The aqueous hydrochloric acid layer was rendered alkaline, extracted three time with 30 ml of chloroform, and the chloroform layer extracted was washed with water and dried with anhydrous magnesium sulfate. After the chloroform was distilled therefrom under reduced pressure, the residue obtained was subjected to a silica gel column chromatography (silica gel: 100 g; solvent: 2% methanol-chloroform) to give 2.60 g of 1-(5-isoquinolinesulfonyl)-4-isobutylpiperazine, i.e., Compound (47) in a yield of 78%. Melting point (the dihydrochloride recrystallized from ethanol): 234° C. Mass spectrum (m/e): 333(M+), 290(M-C3 H7), 141 and 128 NMR spectrum (CDCl3, δ): 0.8(6H, d, 2*CH3), 1.2-2.0(1H, m, CH), 2.0-3.3(10H, 5*NCH2), 7.6-8.8(5H) and 9.3(1H, s) IR absorption spectrum (νmax,cap cm-1): 3430, 1620, 1350, 1340, 1170 and 1145. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
49 8-Benzylthio-2-(N-isobutyl-piperazino)-4-morpholino-pyrimido-[5,4-d]-pyrimidine Example 49 8-Benzylthio-2-(N-isobutyl-piperazino)-4-morpholino-pyrimido-[5,4-d]-pyrimidine This compound was prepared analogous to Example 1 from 8-benzylthio-2-chloro-4-morpholino-pyrimido-[5,4-d]-pyrimidine (m.p.: 159°-161° C.) and N-isobutyl-piperazine. M.p.: 152°-155° C. (ethyl acetate). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
74% | With N-ethyl-N,N-diisopropylamine In water at 200℃; for 2h; Microwave irradiation; Biotage Initiator; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
60% | With N-ethyl-N,N-diisopropylamine In isopropyl alcohol at 45℃; for 18h; | 36 5-Chloro-4-(4-isobutylpiperazin-1-yl)-3-nitropyridin-2-amine To a mixture of 2-amino-4,5-dichloro-3-nitropyridine (0.060 g, 0.29 mmol) and isopropanol (4.5 ml) was added 1-isobutyl-piperazine (0.045 g, 0.32 mmol) with the aid of isopropanol (0.5 ml) followed by diisopropylethylamine (0.06 ml, 0.32 mmol). The reaction mixture was heated at 45° C. for 18 h, then allowed to cool to room temperature, and concentrated in vacuo. The residue was absorbed on silica gel, the free running powder was placed on a 10 g isolute silica column which was eluted with ethyl acetate/dichloromethane (v/v; 1:1). The title compound was obtained as an orange solid (0.054 g, 60%); 1H-NMR (500 MHz, DMSO-d6) 0.87 (d, J=6.57 Hz, 6H, CH(CH3)2), 1.77 (m, 1H, CH(CH3)2), 2.08 (d, J=7.39 Hz, 2H, N-CH2), 2.45 (br s, 4H, piperazine N(CH2)2), 3.05 (br s, 4H, piperazine N(CH2)2), 6.94 (s, 2H, NH2), 8.06 (s, 1H, 6-H);LC (Method B)-MS (ESI, m/z): Rt=1.70 min-314, 316 [(M+H)+, Cl isotopic pattern]. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
63% | With N-ethyl-N,N-diisopropylamine; In isopropyl alcohol; at 45℃; for 20h; | To a mixture of <strong>[942947-95-7]5-bromo-4-chloro-3-nitro-pyridin-2-ylamine</strong> (0.126 g, 0.50 mmol) and isopropanol (9 ml) was added 1-isobutylpiperazine (0.078 g, 0.55 mmol) with the aid of isopropanol (5 ml) followed by diisopropylethylamine (0.10 ml, 0.57 mmol). The reaction mixture was heated at 45 C. for 20 h, then allowed to cool to room temperature. The precipitate was collected by filtration and washed with isopropanol and diethyl ether. The title compound was thus obtained as a yellow solid (0.112 g, 63%). 1H-NMR (500 MHz, DMSO-d6) 0.87 (d, J=6.56 Hz, 6H, CH(CH3)2), 1.77 (m, 1H, CH(CH3)2), 2.08 (d, J=7.35 Hz, 2H, N-CH2), 2.47 (br s, 4H, piperazine N(CH2)2), 3.04 (br s, 4H, piperazine N(CH2)2), 6.96 (s, 2H, NH2), 8.15 (s, 1H, 6-H);LC (Method B)-MS (ESI, m/z): Rt=1.80 min-358, 360 [(M+H)+, Br isotopic pattern]. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
54% | Preparation 16: 4-(4-i-Butylpiperazin-l-yl)cyclohexanamine (cis and trans isomers); [0126] In a 250 mL flask, <strong>[27514-08-5]4-acetamidocyclohexanone</strong> (5.47 g, 35.2 mmol), N-i-butyl piperazine (10 g, 70.3 mmol) were dissolved in dry toluene (75 mL) and added methanesulfonic acid (MSA) (250 muL) and refluxed using Dean-Stark apparatus for five hours with occasional decanting toluene from Dean-Stark apparatus 3-4 times. Then removed half of the toluene from the apparatus and cooled to 500C and added 75 mL ethanol then removed the Dean-Stark apparatus and cooled to 15-200C. Added NaBH4 (35.2 mmol) portion wise under nitrogen atmosphere. Continued stirring the reaction for overnight. Then added NaBH4 (50 mmols), after 30 min added 12 rnL of 4 N HCl drop wise to the reaction. The volatiles were removed from the reaction under reduced pressure. Basified the gummy solid reaction mixture with 12 mL sat.K^CCh, diluted with another 12 mL water and further basified with 50% NaOH solution to pH about 13. Then added EtOAc (100 mL) and filtered the solid product and washed with EtOAc and ether and collected N-(4-(4-i-burtylpiperazin-l-yl)cyclohexyl)acetamide (cis and trans isomers) as white powder (5.3 g, 54%). ESI-MS: m/z 282 (M+H)+. N-(4-(4-propylpiperazin-l- yl)cyclohexyl)acetamide (5.2 g, 18.5 mmol) was refluxed in 24% cone. HCl solution for 20 hours at 115C. Then evaporated the solution under reduced pressure and the solid product obtained was dissolved and recrystallized from isopropyl alcohol to get the product as white hydrochloride salt (5.2 g). ESI-MS: m/z 240 (M+H) +. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In dichloromethane at 0 - 20℃; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
58% | In tert-Amyl alcohol at 110℃; for 4h; | 1 Example 1 : i-^-Fluoro-benzenesulfonyO-pyrrolidine^S-carboxylic acid [2-(4- isobutyl-piperazin-1-yl)-6-(4-trifluoromethyl-phenyl)-pyrimidin-4-ylmethyl]- amide.; To a solution of 1-(4-fluoro-benzenesulfonyl)-pyrrolidine-2S-carboxylic acid [2-phenylmethanesulfonyl-6-(4-trifluoromethyl-phenyl)-pyrimidin-4- ylmethyl]-amide (0.65 g, 0.982 mmol) in f-amyl alcohol (10 mL) was added isobutylpiperazine (0.42 g, 2.95 mmol). The resulting mixture was heated to 110 0C for 4 hours then allowed to cool to rt. The resulting mixture was concentrated and purified by preparative reverse-phase HPLC to afford the title compound as a colorless solid (0.37 g, 58%). MS (ESI): mass calcd. for C3IH36F4N6O3S, 648.2; m/z found, 649.5 [M+H]+. 1H NMR (CDCI3) δ 8.17 (d, J = 8.33 Hz, 2H), 8.07 (t, J = 4.76, 4.76 Hz, 1 H), 7.93-7.88 (m, 2H), 7.72-7.68 (m, 1 H), 7.28-7.22 (m, 2H), 6.95 (s, 1 H), 4.59 (dd, J = 17.56, 5.19 Hz, 1 H), 4.42 (dd, J = 17.56, 4.80 Hz, 1 H), 4.18 (dd, J = 8.79, 2.39 Hz, 1 H), 4.03-3.96 (m, 4H), 3.67-3.57 (m, 1 H), 3.25-3.15 (m, 1 H), 2.57-2.45 (m, 4H), 2.30-2.22 (m, 1 H), 2.14 (d, J = 7.32 Hz, 2H), 1.91-1.75 (m, 2H), 1.74-1.51 (m, 3H), 0.94 (d, J = 6.57 Hz, 6H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In tert-Amyl alcohol at 120℃; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
70% | Stage #1: OZ-78 With triethylamine; methyl chloroformate In dichloromethane at 0℃; for 1h; Inert atmosphere; Stage #2: 1-isobutylpiperazine In dichloromethane at 0 - 20℃; for 2.75h; Inert atmosphere; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With N-ethyl-N,N-diisopropylamine In 1,4-dioxane at 70℃; for 6h; | 190 To a solution of 5-amino-7-chloro-2-(4-fluorophenyl)-oxazolo[5,4-d]pyrimidine X (50 mg, 0.19 mmol) in dioxane (5 ml) was added diisopropylethylamine (0.28 mmol, 47 μL) and a piperazine derivative (0.28 mmol). The reaction was stirred at 70° C. for 6 hours after which the solvent was removed in vacuo. The resulting residue was purified by flash chromatography on silica, the mobile phase being a mixture of methanol and dichloromethane (in a ratio gradually ranging from 100% CH2Cl2 to 2% CH3OH in CH2Cl2), yielding the pure title compounds which were characterized by their mass spectra as indicated below:The following compounds were synthesized according to this procedure:Example 190 Synthesis of 5-amino-2-(4-fluorophenyl)-7-(4-isobutylpiperazin-1-yl)-oxazolo[5,4-d]pyrimidineThis compound was obtained from 1-isobutyl-piperazine (32 mg);MS m/z (%): 371 ([M+H]+, 100). | |
32 mg | With N-ethyl-N,N-diisopropylamine In 1,4-dioxane at 70℃; for 6h; | 190 Example 190 Synthesis of 5-amino-2-(4-fluorophenyl)-7-(4-isobutylpiperazin-1-yl)-oxazolo[5,4-d]pyrimidine Examples 190-192 Synthesis of 5-amino-2-(4-fluorophenyl)-7-piperazin-1-yl-oxazolo[5,4-d]pyrimidine analogues General Procedure [0979] To a solution of 5-amino-7-chloro-2-(4-fluorophenyl)-oxazolo[5,4-d]pyrimidine X (50 mg, 0.19 mmol) in dioxane (5 ml) was added diisopropylethylamine (0.28 mmol, 47 μL) and a piperazine derivative (0.28 mmol). The reaction was stirred at 70° C. for 6 hours after which the solvent was removed in vacuo. The resulting residue was purified by flash chromatography on silica, the mobile phase being a mixture of methanol and dichloromethane (in a ratio gradually ranging from 100% CH2Cl2 to 2% CH3OH in CH2Cl2), yielding the pure title compounds which were characterized by their mass spectra as indicated below: [0980] The following compounds were synthesized according to this procedure: Example 190 Synthesis of 5-amino-2-(4-fluorophenyl)-7-(4-isobutylpiperazin-1-yl)-oxazolo[5,4-d]pyrimidine This compound was obtained from 1-isobutyl-piperazine (32 mg); MS m/z (%): 371 ([M+H]+, 100). |
32 mg | With N-ethyl-N,N-diisopropylamine In 1,4-dioxane at 70℃; for 6h; | 190 Synthesis of 5-amino-2-(4-fluorophenyl)-7-(4-isobutylpiperazin-1-yl)-oxazolo[5,4-d]pyrimidine To a solution of 5-amino-7-chloro-2-(4-fluorophenyl)-oxazolo[5,4-d]pyrimidine X (50 mg, 0.19 mmol) in dioxane (5 ml) was added diisopropylethylamine (0.28 mmol, 47 μL) and a piperazine derivative (0.28 mmol). The reaction was stirred at 70° C. for 6 hours after which the solvent was removed in vacuo. The resulting residue was purified by flash chromatography on silica, the mobile phase being a mixture of methanol and dichloromethane (in a ratio gradually ranging from 100% CH2Cl2 to 2% CH3OH in CH2Cl2), yielding the pure title compounds which were characterized by their mass spectra as indicated below: [0996] The following compounds were synthesized according to this procedure: Example 190 Synthesis of 5-amino-2-(4-fluorophenyl)-7-(4-isobutylpiperazin-1-yl)-oxazolo[5,4-d]pyrimidine [0997] This compound was obtained from 1-isobutyl-piperazine (32 mg); [0998] MS m/z (%): 371 ([M+H]+, 100). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
74% | With manganese(IV) oxide In dimethyl sulfoxide at 20℃; for 24h; | RLZ analog (2e). A mixture of benzoxazinorifamycin 2d (5.5 mg, 0.005 mmol), l-(2- methylpropy piperazine (2.3 mg, 0.016 mmol; Oakwood Products Inc.), Mn02 (5 mg, 0.055 mmol) and DMSO (0.5 mL) was stirred at room temperature for 24 h and then filtered over Celite. The filtrate was concentrated and purified by preparative TLC, eluting with dichloromethane : methanol (90 : 10). The product band was processed to give 2e (4.6 mg, 74%) as a dark blue solid: HPLC 5.33 min (95.3% purity); MS (ES+) m/z 1189.5 (M+H)+; HRMS (MALDI) calcd for C49H61N3O13 [(M + H)+], 1189.6180; found 1189.6193. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
47% | With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide at 20℃; for 3h; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
34% | With potassium carbonate In N,N-dimethyl-formamide at 110℃; for 6h; | 5 2-(6-(4-Isobutylpiperazin-1-yl)pyridin-2-yl)-5,7-dimethoxyquinazolin-4(3H)-one Example 5 2-(6-(4-Isobutylpiperazin-1-yl)pyridin-2-yl)-5,7-dimethoxyquinazolin-4(3H)-one To a suspension of 2-(6-fluoropyridin-2-yl)-5,7-dimethoxyquinazolin-4(3H)-one (0.108 g, 0.36 mmol) in N,N-dimethylformamide (1.5 mL) was added K2CO3 (0.15 g, 1.07 mmol) and 1-isobutyl-piperazine (88.94, 0.54 mmol). The resulting mixture was heated at 110° C. for 6 h. After that time N,N-dimethylacetamide (1.5 mL) was added and heating was continued for 20 h. After that time the reaction mixture was cooled to rt, diluted with ethyl acetate and filtered. The filtrate was concentrated under reduced pressure and the residue was washed with water, and dried under high vacuum. The product was purified by flash column chromatography (silica gel, 99:1 dichloromethane/methanol) to give 2-(6-(4-isobutylpiperazin-1-yl)pyridin-2-yl)-5,7-dimethoxyquinazolin-4(3H)-one (0.052 g, 34%) as a yellow solid: mp 188-189° C.; 1H NMR (400 MHz, CDCl3) δ 10.33 (br s, 1H), 7.83 (d, J=7.42 Hz, 1H), 7.65 (dd, J=8.59, 7.42, 1H), 6.76-6.88 (m, 2H), 6.48 (d, J=2.34 Hz, 1H), 3.99 (s, 3H), 3.94 (s, 3H), 3.64 (t, J=4.88 Hz, 4H), 2.55 (t, J=4.88 Hz, 4H), 2.17 (d, J=7.42 Hz, 2H), 1.75-1.95 (m, 1H), 0.95 (d, J=6.64 Hz, 6H); ESI MS m/z 424 [M+H]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
18% | With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 40℃; | Preparation of Compound 4022, (1-{3-{dimethylammo)propyl}-1/f ndol-'5-yl}{4- tofoutylpiperazin-1-yl)methanone Preparation of Compound 4022, (1-{3-{dimethylammo)propyl}-1/f ndol-'5-yl}{4- tofoutylpiperazin-1-yl)methanone To a solution of 1-(3-(dimethy}arnino)propyl)-1 H-indole-5-carboxylic acid (246 mg, 10 mmol) and 1 -isobutylpiperazine (142 mg, 1.0 mmol) in DMF (10 mL) was added EDCI (384 mg, 2.0 mmol). The mixture was stirred at 40 °C overnight. The reaction mixture was then partitioned between EtOAc and water. The organic layer was washed with water and brine, then dried, concentrated and purified by rep-TLC (MeOH/DCM=1/20) to afford the target product (48 mg, 13%). 1H NMR (400 MHz, CDCI3): 6 7.71 (br s, 1H), 7.38 (d, J - 8.8 Hz, 1 H), 7.29 (del, J ~ 8.4 Hz, 1.2 Hz, 1 H), 7.18 (d, J = 3.2 Hz, 1H), 6.53 (d, J = 3.2 Hz, 1 H), 4.22 (t J = 7.2 Hz, 2H), 3.66 (br s, 4H), 2.42 (br s, 4H), 2.28-2.25 (m, 8H), 2.12 (d, J = 7.6 Hz, 2H), 2.00 (quintet, J ~ 7,6 Hz, 2H), 1.80-170 (m, 1 H), 0.92 (d, J ~ 6,4 Hz, 6H), LC S: m/z 371.3 [M+H3+, |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In acetonitrile at 80℃; for 2h; | 317 N-[3-[5-chloro-2-(difluoromethoxy)phenyl]-1-[2-[4-(2-methylpropyl)piperazin-1-yl]-2-oxoethyl]-1H-pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 2-(Methylsulfanyl)ethan-1-amine (0.5 mL, 5.34 mmol) was added to a solution of N-[1-(2-bromoethyl)-3-[5-chloro-2-(difluoromethoxy)phenyl]-1H-pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide (120 mg, 0.23 mmol) in CH3CN (3 mL). The resulting solution was stirred at 80° C. for 2 h and concentrated under vacuum. The crude product was purified by Prep-HPLC with the following conditions (Prep-HPLC-005): Column, XBridge Prep C18 OBD Column, 5 um, 19*150 mm; mobile phase, water with 10 mmol NH4HCO3 and MeCN (40.0% up to 57.0% in 10 min, up to 95.0% in 1 min, hold 95.0% in 1 min, down to 40.0% in 2 min); Detector, UV 254/220 nm. This resulted in 58.2 mg (48%) of N-[3-[5-chloro-2-(difluoromethoxy)phenyl]-1-(2-[[2-(methylsulfanyl)ethyl]-amino]ethyl)-1H-pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide as a yellow solid. LCMS (Method 20) [M+H]+=522.2, RT=2.50 min. 1H NMR (400 MHz, DMSO-d6) δ: (ppm) 9.73 (s, 1H), 9.34 (dd, 1H, J=1.6, 6.8 Hz), 8.67 (dd, 1H, J=1.6, 4.4 Hz), 8.67 (s, 1H), 8.36 (s, 1H), 7.68-7.61 (m, 2H), 7.46-7.44 (m, 1H), 7.28 (dd, 1H, J=4.4, 7.2 Hz), 7.06 (t, 1H, J=73.2 Hz), 4.23 (t, 2H, J=6.4 Hz), 2.98 (t, 2H, J=6.0 Hz), 2.71 (t, 2H, J=6.8 Hz), 2.53 (t, 2H, J=6.8 Hz), 2.03 (s, 3H). Using synthetic method analoguous to that of N-[3-[5-chloro-2-(difluoromethoxy)phenyl]-1-[2-oxo-2-[4-(1-phenylethyl)piperazin-1-yl]ethyl]-1H-pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide, the title compound was prepared from {3-(5-Chloro-2-difluoromethoxyphenyl)-4-[(pyrazolo[1,5-a]pyrimidine-3-carbonyl)amino]pyrazol-1-yl}acetic acid and 1-(2-methylpropyl)piperazine. LCMS (Method 25) [M+H]+=587.1, RT=1.80 min. 1H NMR (300 MHz, DMSO-d6) δ: (ppm) 9.75 (s, 1H), 9.33 (dd, 1H, J=1.8, 6.9 Hz), 8.68 (dd, 1H, J=1.5, 3.9 Hz), 8.67 (s, 1H), 8.31 (s, 1H), 7.62 (dd, 1H, J=3.0, 8.7 Hz), 7.55 (d, 1H, J=2.7 Hz), 7.45 (d, 1H, J=9.0 Hz), 7.28 (dd, 1H, J=4.2, 7.2 Hz), 7.02 (t, 1H, J=73.2 Hz), 5.23 (s, 2H), 3.57-3.42 (m, 4H), 2.40-2.21 (m, 4H), 2.05 (d, 2H, J=7.2 Hz), 1.81-1.76 (m, 1H), 0.86 (d, 6H, J=6.3 Hz). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
69% | With potassium carbonate In acetonitrile at 80℃; for 16h; | 5 Example 5: N-(l-(lH-Indol-3-yl)hexan-2-yl)-2-(4-isobutylpiperazin-l-yl)thiazole-5- carboxamide. To a solution of N-(l-(lH-indol-3-yl)hexan-2-yl)-2-bromothiazole-5- carboxamide (0.20 g, 0.49 mmol) and 1-isobutylpiperazine (0.05 g, 0.54 mmol) in CH3CN (4.5 mL) was added K2C03 (0.20 g, 1.47 mmol) and the reaction mixture was heated at 80 °C for 16 h. The reaction mixture was concentrated in vacuo. The residue was diluted with H20 (10 mL) and extracted with 10% MeOH in DCM (10 mL). The organic layer was separated, dried over anhydrous Na2S04 and concentrated in vacuo. The crude obtained was purified by column chromatography (silica 230-400 mesh, 0 to 10% MeOH in DCM) and then triturating with petroleum ether (6 mL), pentane (10 mL) and DCM (2 mL) to afford N-(l-(lH-indol-3- yl)hexan-2-yl)-2-(4-isobutylpiperazin-l-yl)thiazole-5-carboxamide (0.16 g, 69%) as an off-white solid. HPLC Purity: 97.4%. LC/MS (ESI) m/e [M+H]+/RT (min)/%: 468.00/3.33/99.52%. 1H NMR (400 MHz, DMSO- 6) δ 0.81 (t, = 6.8 Hz, 3H), 0.87 (d, = 6.4 Hz, 6H), 1.13-1.37 (m, 4H), 1.42-1.58 (m, 2H), 1.76-1.82 (m, 1H), 2.08 (d, = 6.8 Hz, 2H), 2.40-2.48 (m, 4H), 2.73- 2.95 (m, 2H), 3.42-3.48 (m, 4H), 4.10-4.18 (m, 1H), 6.92-6.99 (m, 1H), 7.04 (t, J = 7.3 Hz, 1H), 7.09 (brs, 1H), 7.31 (d, / = 8.3 Hz, 1H), 7.57 (d, = 7.3 Hz, 1H), 7.80 (s, 1H), 7.94 (d, = 8.8 Hz, 1H), 10.75 (brs, 1H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
18.7% | With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In N,N-dimethyl-formamide at 20℃; for 20h; | 6.2.1. tert-Butyl 3-(4-carbamoyl-1H-benzo[d]imidazole-2-carboxamido)pyrrolidine-1-carboxylate (7a) General procedure: A mixture of 2-carboxyl-1H-benzo[d]immidazole-4-carboxamide (75 mg, 0.37 mmol), EDC (210 mg, 1.09 mmol), HOBt(147 mg, 1.09 mmol), Et3N (0.4 mL, 2.93 mmol) and N-Boc-aminopyrrolidine(202 mg, 1.09 mmol) in DMF (5 mL) was stirred atroom temperature for 20 h and then H2O was added to the mixture.The solutionwas extracted with the solvent mixture (ethyl acetate/methanol = 10:1) (30 mL x 3) and then the organic layer waswashed with brine (20 mL x 2). The combined organic layer wasdried over anhydrous MgSO4. After filtration and concentration, thecrude product was obtained and purified with column chromatography(methylene chloride/methanol 50:1 to 40:1) to givecompound 7a as a white solid (74 mg, 54.4%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
0.022 g | Stage #1: 2-phenyl-1H-benzo[d]imidazole-6-carboxylic acid With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃; for 0.5h; Stage #2: 1-isobutylpiperazine With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 18h; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: N-ethyl-N,N-diisopropylamine / ethanol / 36 h / 60 °C 2: acetic acid; palladium on activated charcoal; hydrogen / methanol / 4 h / 25 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 4 steps 1: N-ethyl-N,N-diisopropylamine / ethanol / 36 h / 60 °C 2: acetic acid; palladium on activated charcoal; hydrogen / methanol / 4 h / 25 °C 3: tris-(dibenzylideneacetone)dipalladium(0); caesium carbonate; dicyclohexyl-(2′,4′,6′-triisopropyl-3,6-dimethoxy-[1,1′-biphenyl]-2-yl)phosphine / <i>tert</i>-butyl alcohol; toluene / 110 °C / Inert atmosphere 4: trifluoroacetic acid / neat (no solvent) / 12 h / 100 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 3 steps 1: N-ethyl-N,N-diisopropylamine / ethanol / 36 h / 60 °C 2: acetic acid; palladium on activated charcoal; hydrogen / methanol / 4 h / 25 °C 3: tris-(dibenzylideneacetone)dipalladium(0); caesium carbonate; dicyclohexyl-(2′,4′,6′-triisopropyl-3,6-dimethoxy-[1,1′-biphenyl]-2-yl)phosphine / <i>tert</i>-butyl alcohol; toluene / 110 °C / Inert atmosphere |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With manganese(IV) oxide In dimethyl sulfoxide at 25℃; for 24h; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
55% | With triethylamine In dichloromethane at 20℃; for 24h; | |
50 mg | Stage #1: 1-isobutylpiperazine With triethylamine In dichloromethane at 20℃; for 0.166667h; Stage #2: 4-formylbenzene-1-sulfonyl chloride In dichloromethane at 20℃; for 24h; | General procedure: General procedure 4 (23a-aa, 24a-l). To a solution of the corresponding amine (0.29 mmol, 1 Eq.) in DCM (1 ml) was added Triethylamine (0.88 mmol, 3 Eq.). After stirring at room temperature for 10 min., a solution of formylbenzenesulfonyl chloride (21) (0.29 mmol, 1 Eq.) in DCM (1 ml) was added. The reaction mixtures was then stirred at room temperature overnight. After complete consumption of the starting materials - monitored by TLC (DCM/MeOH 9: 1) and UHPLC-MS - The reaction mixture was diluted with a saturated solution NaHCO3 (1 ml). The organic layer was separated, dried over magnesium sulfate, and concentrated under reduced pressure. Compound was purified by preparative HPLC. |
50 mg | Stage #1: 1-isobutylpiperazine With triethylamine In dichloromethane at 20℃; for 0.166667h; Stage #2: 4-formylbenzene-1-sulfonyl chloride In dichloromethane at 20℃; for 24h; | General procedure: General procedure 4 (23a-aa, 24a-l). To a solution of the corresponding amine (0.29 mmol, 1 Eq.) in DCM (1 ml) was added Triethylamine (0.88 mmol, 3 Eq.). After stirring at room temperature for 10 min., a solution of formylbenzenesulfonyl chloride (21) (0.29 mmol, 1 Eq.) in DCM (1 ml) was added. The reaction mixtures was then stirred at room temperature overnight. After complete consumption of the starting materials - monitored by TLC (DCM/MeOH 9: 1) and UHPLC-MS - The reaction mixture was diluted with a saturated solution NaHCO3 (1 ml). The organic layer was separated, dried over magnesium sulfate, and concentrated under reduced pressure. Compound was purified by preparative HPLC. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
30% | Stage #1: 1-isobutylpiperazine With cesium fluoride; trimethylamine In acetonitrile at 20℃; for 0.333333h; Stage #2: 3-fluoro-4-nitro-benzaldehyde In acetonitrile at 20℃; for 24h; Stage #3: formic acid In water; acetonitrile |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
77.6% | With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 20℃; | General method for preparation of compounds 3a-3h,4a-4i, 5a-5k, and 6a-6d General procedure: Phenylacetic acid derivative (0.01 mol) or 3-(4-(trifluoromethyl)phenyl) propionic (0.01 mol) and L-tryptophanmethyl ester hydrochloride (0.01 mol) were added to anhydrousDCM; (100 mL), then Et3N (0.04 mol) was added, andthen the mixture was stirred for 10 min. 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDCI)(0.012 mol) and 1-Hydroxybenzotriazole (HOBt)(0.7 mmol) were added and the mixture was stirred overnightat room temperature. Thereafter, the mixture waswashed with 0.1 N sodium hydroxide solution, 0.1 N HCl,and water. The organic layer was concentrated underreduced pressure to produce intermediates 1a-1i. Intermediate1 (5.0 mmol) was dissolved in methanol (20 mL) and heated to 60 oC. 1 N NaOH (10 mL) was added dropwiseand then stirred for 2 h at 60 oC. The reaction mixturewas cooled to room temperature, and the pH was adjusted to2-3 with HCl solution. The cake was filtered, washed withwater, and then dried under reduced pressure to obtainintermediates 2a-2i. Intermediate 2 (1.0 mmol) and variousamino derivatives (1.1 mmol) were added to anhydrousDCM (15 mL) and then Et3N (4.0 mmol), EDCI (1.2 mmol),and HOBt (0.07 mmol) were added. The mixture was stirredovernight at room temperature. Thereafter, the mixture waswashed with water, and then the crude product was crystallizedfrom methanol/water or purified by silica gel forcolumn chromatography (DCM/methanol) to obtain thetargeted product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
30% | Stage #1: 1-isobutylpiperazine With triethylamine; cesium fluoride In acetonitrile at 20℃; for 0.333333h; Stage #2: 3-fluoro-4-nitro-benzaldehyde In acetonitrile at 20℃; Stage #3: formic acid In water; acetonitrile | General procedure: General procedure 1 (13a-u). A solution of the corresponding amine (12a-u) (0.46 mmol, 1.3 Eq.), trimethylamine (1.06 mmol, 3 Eq.) and cesium fluoride (0.03 mmol, 0.1 Eq.) in ACN (1 ml) was stirred at room temperature for 20 min. To the reaction mixture was then added a solution of 3-fluoro-4-nitrobenzaldehyde (11) (0.35 mmol, 1 Eq.) in CAN (0.5 ml). The resulting reaction was then stirred at room temperature for 24 hours. After complete consumption of the starting materials - monitored by TLC (DCM/MeOH 19:1) and UHPLC-MS the mixture was filtered, and filtrate was evaporated under reduced pressure. Compound was purified by preparative HPLC. 3-(3-methoxyazetidin-1-yl)-4-nitrobenzaldehyde (13a). Compound 13a was synthesized using general procedure 1 and 3-azetidinyl methyl ether hydrochloride (12a). The crude reaction was purified using preparative HPLC to afford the desired compound as an orange amorphous solid (26 mg, 30% yield) with a purity of 98% by UHPLC-MS. |
30% | Stage #1: 1-isobutylpiperazine With triethylamine; cesium fluoride In acetonitrile at 20℃; for 0.333333h; Stage #2: 3-fluoro-4-nitro-benzaldehyde In acetonitrile at 20℃; Stage #3: formic acid In water; acetonitrile | General procedure: General procedure 1 (13a-u). A solution of the corresponding amine (12a-u) (0.46 mmol, 1.3 Eq.), trimethylamine (1.06 mmol, 3 Eq.) and cesium fluoride (0.03 mmol, 0.1 Eq.) in ACN (1 ml) was stirred at room temperature for 20 min. To the reaction mixture was then added a solution of 3-fluoro-4-nitrobenzaldehyde (11) (0.35 mmol, 1 Eq.) in CAN (0.5 ml). The resulting reaction was then stirred at room temperature for 24 hours. After complete consumption of the starting materials - monitored by TLC (DCM/MeOH 19:1) and UHPLC-MS the mixture was filtered, and filtrate was evaporated under reduced pressure. Compound was purified by preparative HPLC. 3-(3-methoxyazetidin-1-yl)-4-nitrobenzaldehyde (13a). Compound 13a was synthesized using general procedure 1 and 3-azetidinyl methyl ether hydrochloride (12a). The crude reaction was purified using preparative HPLC to afford the desired compound as an orange amorphous solid (26 mg, 30% yield) with a purity of 98% by UHPLC-MS. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
49% | With potassium carbonate In 1-methyl-pyrrolidin-2-one Heating; Inert atmosphere; | 13 Example 12 Preparation of Compounds 3-15 Using compound 2 (200mg, 311μmol, 1.0eq) as the starting material, K2CO3 (216mg, 1.56mmol, 5.0eq) as the base, N-isobutylpiperazine (0.963mL, 6.22mmol, 20.0eq) as the parent The nuclear reagent, NMP as the solvent, was prepared by referring to the general synthetic method to obtain the crude product.The crude product was purified by silica gel column chromatography (petroleum ether:ethyl acetate (v:v)=3:1) to obtain compound 3-15 (113 mg, 49%) as a pale yellow powder, and part of the sample was further analyzed by normal phase preparative HPLC (PrepSilica OBDTM 5μm, 30×100mm column, flow rate: 25mL/min, temperature: 25°C, n-hexane:isopropanol (v:v)=90:10-85:15-75:25) Purification used to collect spectra and determination of purity data. Purity: 98.1727%; |
[ 57184-50-6 ]
1-(2,2-Dimethylpropyl)piperazine
Similarity: 1.00
[ 4649-58-5 ]
2-(4-Isobutylpiperazin-1-yl)ethanamine
Similarity: 1.00
[ 33174-08-2 ]
1-Isobutylpiperazine dihydrochloride
Similarity: 0.95
[ 510725-53-8 ]
1-Isobutylpiperazine hydrochloride
Similarity: 0.95
[ 879059-43-5 ]
2,2-Dimethyl-3-(4-methylpiperazin-1-yl)propan-1-amine
Similarity: 0.95